Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$56.34
-1.4%
$58.54
$47.31
$87.32
$2.62B0.53870,427 shs893,167 shs
Neogen Corporation stock logo
NEOG
Neogen
$8.19
-2.8%
$9.28
$4.53
$11.43
$1.78B1.842.18 million shs1.52 million shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$10.32
-9.4%
$14.76
$9.92
$35.58
$703.73M0.752.63 million shs2.45 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$10.07
-3.3%
$11.72
$9.85
$17.09
$2.02B0.934.71 million shs9.07 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.33%-6.44%-2.49%-17.51%
Neogen Corporation stock logo
NEOG
Neogen
0.00%-9.50%-11.36%-25.14%+28.37%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
0.00%-4.44%-18.68%-56.23%-69.24%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.00%-8.45%-16.71%-22.24%-38.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$56.34
-1.4%
$58.54
$47.31
$87.32
$2.62B0.53870,427 shs893,167 shs
Neogen Corporation stock logo
NEOG
Neogen
$8.19
-2.8%
$9.28
$4.53
$11.43
$1.78B1.842.18 million shs1.52 million shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$10.32
-9.4%
$14.76
$9.92
$35.58
$703.73M0.752.63 million shs2.45 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$10.07
-3.3%
$11.72
$9.85
$17.09
$2.02B0.934.71 million shs9.07 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+2.33%-6.44%-2.49%-17.51%
Neogen Corporation stock logo
NEOG
Neogen
0.00%-9.50%-11.36%-25.14%+28.37%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
0.00%-4.44%-18.68%-56.23%-69.24%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.00%-8.45%-16.71%-22.24%-38.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.82
Moderate Buy$79.3340.81% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.17
Hold$10.6730.24% Upside
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.50
Reduce$14.8844.14% Upside
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.00
Hold$13.8237.22% Upside

Current Analyst Ratings Breakdown

Latest QDEL, HAE, XRAY, and NEOG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Reiterated RatingOutperform
5/12/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Lower Price TargetOutperform$94.00 ➝ $89.00
5/8/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Set Price Target$67.00
5/8/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Lower Price TargetNeutral$74.00 ➝ $62.00
5/7/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Reiterated RatingNeutral$12.00
5/7/2026
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Lower Price TargetBuy$18.00 ➝ $17.00
5/7/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
DowngradeBuyHold$35.00 ➝ $12.50
5/6/2026
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
DowngradeSell (D-)Sell (E+)
5/6/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Lower Price TargetNeutral$30.00 ➝ $13.00
5/6/2026
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Lower Price TargetNeutral$16.00 ➝ $14.00
4/21/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Reiterated RatingSell (E+)
(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B1.96$7.58 per share7.43$17.14 per share3.29
Neogen Corporation stock logo
NEOG
Neogen
$894.66M1.99$5.77 per share1.42$9.54 per share0.86
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$2.73B0.26$19.11 per share0.54$27.15 per share0.38
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.68B0.55$5.99 per share1.68$6.58 per share1.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0227.899.801.137.29%27.30%9.59%N/A
Neogen Corporation stock logo
NEOG
Neogen
-$1.09B-$2.80N/A37.233.56-69.93%2.35%1.46%8/4/2026 (Estimated)
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-$1.13B-$17.82N/A4.14N/A-45.57%4.25%1.56%7/29/2026 (Estimated)
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$598M-$3.15N/A6.501.20-17.06%18.83%5.13%N/A

Latest QDEL, HAE, XRAY, and NEOG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q4 2026
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.28$1.29+$0.01-$0.44$336.83 million$346.35 million
5/5/2026Q1 2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$0.37-$0.04-$0.41-$1.35$665.23 million$619.80 million
5/5/2026Q1 2026
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.28$0.27-$0.01-$0.05$841.80 million$880.00 million
4/9/2026Q3 2026
Neogen Corporation stock logo
NEOG
Neogen
$0.04$0.09+$0.05-$0.08$204.62 million$211.20 million
2/26/2026Q4 2025
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.28$0.27-$0.01-$0.74$926.40 million$961.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.646.36%+9.86%N/A 13 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.53
2.95
1.87
Neogen Corporation stock logo
NEOG
Neogen
0.38
3.92
2.84
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.33
1.43
0.80
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
1.52
1.53
0.98

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
Neogen Corporation stock logo
NEOG
Neogen
96.73%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
99.00%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
1.84%
Neogen Corporation stock logo
NEOG
Neogen
0.55%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
0.79%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,02346.47 million45.62 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.67 million216.48 millionOptionable
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
6,50068.19 million67.65 millionOptionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
14,000200.33 million199.33 millionOptionable

Recent News About These Companies

DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
DENTSPLY SIRONA Q1 Earnings Call Highlights
Dentsply Sirona Reports First Quarter 2026 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Haemonetics stock logo

Haemonetics NYSE:HAE

$56.34 -0.78 (-1.36%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$55.96 -0.38 (-0.67%)
As of 05/15/2026 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Neogen stock logo

Neogen NASDAQ:NEOG

$8.19 -0.24 (-2.85%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$8.20 +0.01 (+0.06%)
As of 05/15/2026 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$10.32 -1.07 (-9.39%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$10.35 +0.03 (+0.29%)
As of 05/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

DENTSPLY SIRONA stock logo

DENTSPLY SIRONA NASDAQ:XRAY

$10.07 -0.34 (-3.27%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$10.11 +0.04 (+0.40%)
As of 05/15/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina